Home › Funds › TENOR CAPITAL MANAGEMENT Co., L.P. › IONS

TENOR CAPITAL MANAGEMENT Co., L.P. position in IONS

IONIS PHARMACEUTICALS INC · Health Care

TENOR CAPITAL MANAGEMENT Co., L.P. reported holding 94,682,000 shares of IONS (IONIS PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$147.8M, representing 2.74% of its reported portfolio and ranking #3 among its reported holdings. TENOR CAPITAL MANAGEMENT Co., L.P. has disclosed IONS holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)94.68M sh
Reported value held$147.77M
Portfolio Weight2.74%
First reportedQ3 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How TENOR CAPITAL MANAGEMENT Co., L.P.'s IONS position evolved

TENOR CAPITAL MANAGEMENT Co., L.P. first disclosed a stake in IONS in Q3 2023 at 32,000,000 shares (US$31.37B). The position peaked in Q1 2025 at 96,292,000 shares, worth US$95.41B. Across 12 filings, TENOR CAPITAL MANAGEMENT Co., L.P. increased the stake 6 time(s), trimmed it 3 time(s) and left it unchanged 2 time(s). The most recent filing (Q2 2026) shows 94,682,000 shares valued at US$147.8M — an increase of 72,972,000 shares quarter over quarter.. Notable position changes include a 790% increase in Q3 2024 (shares fell 13% over the following quarter), a 712% increase in Q3 2025 (shares rose 21% over the following quarter), a 336% increase in Q2 2026 (shares fell 44% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 32.00M $31.37B New
Q4 2023 32.00M $33.78B Hold
Q1 2024 52.00M $51.37B Add
Q2 2024 10.00M $11.05B Reduce
Q3 2024 89.00M $88.92B Add
Q4 2024 89.00M $86.43B Hold
Q1 2025 96.29M $95.41B Add
Q2 2025 8.00M $8.41M Reduce
Q3 2025 65.00M $80.03M Add
Q4 2025 10.75M $17.10M Reduce
Q1 2026 21.71M $32.94M Add
Q2 2026 94.68M $147.77M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About IONS and 13F data

IONS (IONIS PHARMACEUTICALS INC) is a Health Care company. 41 other funds we track also report a position in IONS — the largest reported positions include Two Sigma Investments (US$495.7M), TWO SIGMA ADVISERS, LP (US$241.5M), Tweedy, Browne Co LLC (US$180.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding IONS

All IONS fund holders →

FAQ

How long has TENOR CAPITAL MANAGEMENT Co., L.P. held IONS?

TENOR CAPITAL MANAGEMENT Co., L.P. has disclosed IONS holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is TENOR CAPITAL MANAGEMENT Co., L.P.'s current position in IONS?

As of Q2 2026, TENOR CAPITAL MANAGEMENT Co., L.P. holds 94.68M shares of IONS (IONIS PHARMACEUTICALS INC), valued at $147.77M, representing 2.74% of its reported portfolio and ranking #3.

Has TENOR CAPITAL MANAGEMENT Co., L.P. been buying or selling IONS?

In the latest 13F filing (Q2 2026), TENOR CAPITAL MANAGEMENT Co., L.P. increased its position in IONS. The position peaked in Q1 2025 at 96.29M shares.

Which other funds hold IONS?

Other major institutional holders of IONS include Two Sigma Investments, TWO SIGMA ADVISERS, LP, Tweedy, Browne Co LLC, among 41 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.